Navignostics
Precision cancer diagnostics
Navignostics has raised €8.6M across 2 funding rounds from 2 investors, most recently a round in Nov 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of Nov 2026.
Total raised
€8.6M
€8,635,217
Funding rounds
2
Investors
2
distinct backers
Active since
2022-09
latest 2022-11
Funding by year
EUR raised per yearNavignostics — funding by year — interactive chart.
Data table
| Navignostics — funding by year | |
|---|---|
| 2022 | €8.6M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-11 | Other | €7.6M | Bruker Invest | View deal → |
| 2022-09-02 | Debt | €1.0M | UZH Life Science Fund | View deal → |
Investors
2Related news
- UZH Life Science Fund invests in Navignosticsstartupticker.ch · 2022-09
- startupticker.ch
Similar companies
same sector, similar sizeGlobal coverage: FundingData